Modeled Urea Distribution Volume and Mortality in the HEMO Study

Background and objectives in the Hemodialysis (HEMO) Study, observed small decreases in achieved equilibrated Kt/V-urea a were noncausally associated with markedly increased mortality. Here we examine the association of mortality with modeled volume (V-m), the denominator of equilibrated Kt/V-urea. Design, setting, participants, & measurements Parameters derived from modeled urea kinetics (including V-m) and blood pressure (BP) were obtained monthly in 1846 patients. Case mix adjusted time-dependent Cox regressions were used to relate the relative mortality hazard at each time point to V-m and to the change in V-m, over the preceding 6 months. Mixed effects models were used to relate V-m to changes in intradialytic systolic BP and to other factors at each follow-up visit. Results Mortality was associated with Vn, and change in V-m over the preceding 6 months. The association between change in V-m and mortality was independent of vascular access complications. In contrast, mortality was inversely associated with V calculated from anthropometric measurements (V-ant. In case mix adjusted analysis using V-m as a time-dependent covariate, the association of mortality with V-m strengthened after statistical adjustment for V-ant. After adjustment for Van, higher V-m was associated with slightly smaller reductions in intradialytic systolic BP and with risk factors for mortality including recent hospitalization and reductions in serum albumin concentration and body weight. Conclusions An increase in Vn, is a marker for illness and mortality risk in hemodialysis patients. Clin J Am Soc Nephrol 6: 1129-1138, 2011. doi: 10.2215/CJN.06340710